Generally, the lipid DG functions as a second messenger by activating the PKC- as well as the protein kinase D (PKD) signaling pathways, regulating cell cycle development thereby, mobile survival, malignant transformation, apoptosis, and melanogenesis [71,72,73]

Generally, the lipid DG functions as a second messenger by activating the PKC- as well as the protein kinase D (PKD) signaling pathways, regulating cell…

Empagliflozin groups showed smaller atherosclerotic plaque areas in the aortic arch/valve, and lower insulin resistance and inflammation markers (TNF-, interleukin [IL]-6, monocyte chemoattractant protein-1, etc

Empagliflozin groups showed smaller atherosclerotic plaque areas in the aortic arch/valve, and lower insulin resistance and inflammation markers (TNF-, interleukin [IL]-6, monocyte chemoattractant protein-1, etc.)…